The Cooper Companies, Inc.COO

$65.91+0.86 (+1.32%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$13B
Large-cap
+46%
2016 — today
10-Year Price
+46%
2016 — today
52-Week Range
$58.98$84.32
Current $65.91· 27%

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

Valuation in context

P/E ratio
55.9
Near historic high
Near historic highs — last 10 years
P/B ratio
1.6
Near historic low
Near historic low — last 10 years
EV / EBITDA
22.5
Around average
Around the 10-year average
FCF Yield
2.5%
Below average
Below the 10-year average
Free · No credit card needed

Get alerted when COO is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.